Jonathan M Blau, MD
Orthopedic Surgery · Encino
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 16 years
- Graduated 2010
Offices
1 location · Shahin S Rad MD PC · 14 clinicians in this group
Hospitals listed: Valley Presbyterian Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Blau’s office at (818) 477-0787 to ask if they take your plan before you enroll.
California Medical Board record
Licence A141061 · Current
Licensed to practise in California · since 2016 · expires 2028-03-31 · University of Southern California Keck School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Valley Presbyterian HospitalVan Nuys, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.049, Oct 2024 – Sep 2025
See every measure and the patient survey for Valley Presbyterian Hospital
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.049 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0 to 2.02) · 594 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.48 to 1.25) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 156.9 (96.19 to 217.61) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 216 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.1 · 70 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 1,116 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.02 to 0.45) · 3,518 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,606 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.27 (0.88 to 5.65) · 646 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 217 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.04 (0.42 to 3.66) · 635 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.41 (0 to 16.47) · 226 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.87 (0.68 to 9.06) · 208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 125 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1.24) · 3,088 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.574 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.06 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.874 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.935 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 84 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 271 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 83.7 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 59.4 · 264 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.7 · 360 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 359 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.2 to 17) · 88 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 56 cases | No different | Jan 2024 – Dec 2024 |
What patients said (397 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 1 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 61% |
| Doctors "always" listened carefully | 66% |
| Doctors "always" treated them with courtesy and respect | 72% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 66% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 76% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$36,354
Medicare paid this office $36,354 for 107 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 59 | $5,683 | $69 |
| New patient visit (30+ min) | 22 | $1,910 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,703 | $142 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,626 | $56 |
| X-ray of both hips, minimum of 5 views | 22 | $1,511 | $52 |
See all 9 services
| Short return visit (20+ min) | 59 | $5,683 | $69 |
| New patient visit (30+ min) | 22 | $1,910 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,703 | $142 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,626 | $56 |
| X-ray of both hips, minimum of 5 views | 22 | $1,511 | $52 |
| X-ray of knee, 4 or more views | 27 | $1,496 | $40 |
| Return visit (30+ min) | 14 | $1,232 | $88 |
| X-ray of knee, 3 views | 14 | $930 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $49 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Knee replacement | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 25 | 24 | – | – | 44 | 29 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
107 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 10% · Women 59% · Also on Medicaid 61% · Health risk score 1.79. Sicker patients than 9 in 10 peers; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 48% · Coronary heart disease 35% · Depression 32% · Chronic kidney disease 26% · Heart failure 24% · Atrial fibrillation 19% · COPD 17% · Cancer 14% · Dementia 11% · Stroke 10%.
The office billed $143,301, Medicare allowed $48,562 and paid $36,354; for 411 services of 47 kinds; $3,330 of it was for drugs given in the office and $33,024 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 107 | 411 | 73 | 1.79 | $143,301 | $36,354 |
| 2023 | 112 | 524 | 74 | 1.55 | $216,839 | $55,554 |
| 2022 | 34 | 76 | 75 | 1.37 | $50,919 | $11,403 |
| 2021 | 13 | 56 | 81 | 2.33 | $42,225 | $9,961 |
| 2020 | 65 | 371 | 75 | 2.26 | $155,889 | $38,977 |
| 2019 | 79 | 360 | 74 | 2.06 | $124,317 | $32,883 |
| 2018 | 381 | 1,813 | 76 | 1.46 | $401,950 | $105,487 |
| 2017 | 285 | 940 | 74 | 1.36 | $294,748 | $48,979 |
| 2016 | 49 | 58 | 73 | 1.08 | $74,898 | $5,092 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 61 | $6,515 | $74 |
| X-ray of knee, 4 or more views | 35 | $2,237 | $43 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,180 | $145 |
| X-ray of both hips, minimum of 5 views | 23 | $2,049 | $53 |
| Aspiration and/or injection of fluid from large joint | 27 | $1,956 | $61 |
| New patient visit (30+ min) | 20 | $1,742 | $87 |
| Return visit (30+ min) | 13 | $1,436 | $110 |
| X-ray of knee, 3 views | 17 | $900 | $32 |
| Aspiration and/or injection of fluid from large joint | 12 | $264 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $89 | None |
2020: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,974 | $175 |
| Return visit (30+ min) | 22 | $2,027 | $88 |
| Short return visit (20+ min) | 20 | $1,400 | $58 |
| Aspiration and/or injection of fluid from large joint | 14 | $1,110 | $46 |
| X-ray of knee, 4 or more views | 14 | $797 | $35 |
| X-ray of both hips, minimum of 5 views | 11 | $615 | $51 |
| X-ray of knee, 3 views | 11 | $442 | $32 |
2019: 8 services
| Short return visit (20+ min) | 39 | $2,782 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,441 | $174 |
| Return visit (30+ min) | 22 | $2,411 | $96 |
| Aspiration and/or injection of fluid from large joint | 18 | $1,144 | $46 |
| X-ray of both hips, minimum of 5 views | 12 | $662 | $51 |
| X-ray of knee, 4 or more views | 12 | $654 | $38 |
| X-ray of knee, 3 views | 11 | $388 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $84 | None |
2018: 15 services
| Short return visit (20+ min) | 197 | $15,447 | $56 |
| Replacement of knee joint, both sides of knee | 22 | $11,155 | $507 |
| New patient visit (30+ min) | 126 | $10,281 | $82 |
| Aspiration and/or injection of fluid from large joint | 85 | $5,628 | $55 |
| Return visit (30+ min) | 50 | $4,922 | $89 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 15 | $3,761 | None |
| X-ray of knee, 3 views | 69 | $2,942 | $29 |
| X-ray of knee, 4 or more views | 56 | $2,661 | $34 |
| X-ray of knee, 1-2 views | 64 | $2,592 | $26 |
| X-ray of hip, 2-3 views | 61 | $2,437 | $32 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 19 | $2,109 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,730 | $115 |
| X-ray of shoulder, minimum of 2 views | 23 | $879 | $26 |
| Emergency department visit with low level of medical decision making | 12 | $665 | $51 |
| Injection, methylprednisolone acetate, 40 mg | 53 | $361 | None |
2017: 14 services
| Short return visit (20+ min) | 68 | $5,144 | $63 |
| New patient visit (30+ min) | 47 | $4,314 | $92 |
| Aspiration and/or injection of fluid from large joint | 35 | $3,021 | $63 |
| Return visit (30+ min) | 29 | $2,795 | $90 |
| Replacement of knee joint, both sides of knee | 15 | $2,647 | $176 |
| X-ray of hip, 2-3 views | 30 | $1,199 | $37 |
| Short return visit (20+ min) | 32 | $1,170 | $35 |
| Aspiration and/or injection of fluid from large joint | 27 | $1,047 | $37 |
| X-ray of knee, 3 views | 24 | $1,036 | $31 |
| X-ray of knee, 1-2 views | 25 | $832 | $28 |
| Return visit (30+ min) | 19 | $775 | $41 |
| X-ray of shoulder, minimum of 2 views | 20 | $626 | $26 |
| X-ray of knee, 4 or more views | 14 | $572 | $32 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $125 | None |
2016: 1 service
| Aspiration and/or injection of fluid from large joint | 17 | $674 | $37 |
Medicaid work
$48,016 in 2024
Medicaid paid $48,016 for 690 billed services this clinician did in 2024, up to 45 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 283 | $35,343 |
| Arthrocentesis and injection of knee joint | 124 | $4,410 |
| New patient visit (45+ min) | 43 | $3,805 |
| Radiologic examination, knee; complete, 4 or more views | 111 | $1,712 |
| Short return visit (20+ min) | 22 | $1,003 |
| New patient visit (30+ min) | 13 | $979 |
| Radiologic examination, hips, bilateral, with pelvis when performed; minimum of 5 views | 18 | $661 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $103 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 14 | $0 |
| 2024 | 690 | 9 | 45 | $48,016 |
| 2023 | 713 | 7 | 43 | $61,195 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 232 | $38,673 |
| New patient visit (45+ min) | 58 | $8,027 |
| Arthrocentesis and injection of knee joint | 114 | $6,664 |
| Radiologic examination, hips, bilateral, with pelvis when performed; minimum of 5 views | 109 | $4,721 |
| Radiologic examination, knee; complete, 4 or more views | 123 | $2,863 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $248 |
| Postoperative follow-up visit, normally included in the surgical package, to indicate that an evaluation and management service was performed during a postoperative period for a reason(s) related to the original procedure | 15 | $0 |
Drugs they prescribed that Part D paid
$1,675
Pharmacies billed $1,675 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (14 of 217) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
217 generic and 0 brand-name prescriptions · $1,675 in drug cost · 22 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac | 19 | $906 | $48 |
| Meloxicam | 103 | $308 | $3 |
| Oxycodone | 11 | $83 | $8 |
| Gabapentin | 23 | $77 | $3 |
| Ondansetron | 14 | $77 | $5 |
See all 7 drugs
| Diclofenac | 19 | $906 | $48 |
| Meloxicam | 103 | $308 | $3 |
| Oxycodone | 11 | $83 | $8 |
| Gabapentin | 23 | $77 | $3 |
| Ondansetron | 14 | $77 | $5 |
| Amoxicillin | 21 | $73 | $3 |
| Pantoprazole | 11 | $51 | $5 |
Year by year
| 2024 | 217 | 75 | 7% (14) | 0% | $1,675 |
| 2023 | 267 | 81 | 4% (11) | None | $4,406 |
| 2022 | 272 | 85 | 7% (20) | None | $4,984 |
| 2021 | 186 | 66 | 6% (11) | None | $2,860 |
| 2020 | 141 | 45 | 8% (11) | 0% | $2,469 |
| 2019 | 104 | 48 | 15% (16) | None | $1,872 |
| 2018 | 124 | 72 | 22% (27) | 10% | $2,843 |
| 2017 | 95 | 63 | 28% (27) | None | $1,468 |
| 2016 | 49 | 33 | 37% (18) | None | $632 |
| 2015 | 22 | 14 | 68% (15) | None | $329 |
| 2014 | 43 | 28 | 49% (21) | None | $2,917 |
| 2013 | 11 | None | None | 0% | $100 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Diclofenac | 29 | $1,980 | $68 |
| Meloxicam | 146 | $875 | $6 |
| Pantoprazole | 14 | $119 | $8 |
| Gabapentin | 22 | $104 | $5 |
| Ondansetron | 16 | $89 | $6 |
2022: 5 drugs
| Diclofenac | 48 | $2,196 | $46 |
| Meloxicam | 127 | $501 | $4 |
| Ondansetron | 14 | $149 | $11 |
| Oxycodone | 13 | $110 | $8 |
| Gabapentin | 22 | $74 | $3 |
2021: 3 drugs
| Diclofenac | 24 | $1,613 | $67 |
| Meloxicam | 92 | $378 | $4 |
| Gabapentin | 31 | $110 | $4 |
2020: 4 drugs
| Diclofenac | 47 | $1,833 | $39 |
| Meloxicam | 54 | $224 | $4 |
| Gabapentin | 15 | $37 | $2 |
| Amoxicillin | 11 | $27 | $2 |
2019: 4 drugs
| Diclofenac | 31 | $1,110 | $36 |
| Meloxicam | 29 | $132 | $5 |
| Oxycodone | 11 | $116 | $11 |
| Gabapentin | 14 | $76 | $5 |
2018: 4 drugs
| Hydrocodone-Acetaminophen | 13 | $184 | $14 |
| Meloxicam | 31 | $131 | $4 |
| Gabapentin | 25 | $88 | $4 |
| Amoxicillin | 11 | $39 | $4 |
2017: 3 drugs
| Oxycodone | 12 | $316 | $26 |
| Meloxicam | 35 | $106 | $3 |
| Amoxicillin | 11 | $42 | $4 |
2016: 2 drugs
| Oxycodone | 16 | $334 | $21 |
| Meloxicam | 12 | $56 | $5 |
Money from drug and device companies
$1,054 in 2025
| 2025 | 6 | 18 | None | $1,054 |
| 2024 | 9 | 10 | None | $284 |
| 2023 | 2 | 2 | None | $49 |
| 2022 | 2 | 2 | None | $88 |
| 2021 | 2 | 3 | None | $89 |
| 2020 | 1 | 2 | None | $60 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Zimmer Biomet Holdings | Comprehensive Shoulder System | $353 | 3 payments
|
| Medtronic | Intellis Adaptivestim | $278 | 10 payments
|
| Uoc USA | U-Star, Conformity, U2 | $188 | 1 payment
|
| Saxum Surgical | None | $113 | 1 payment
|
| Stryker | Gamma | $62 | 1 payment
|
| ConvaTec | Aquacel Ag+ Extra | $60 | 2 payments
|
See all 18 published payments
| Zimmer Biomet Holdings | Meals · 2025-11-21 | Avitus Bone Harvester | $145 |
| Medtronic | Meals · 2025-10-28 | Intellis Adaptivestim | $32 |
| Medtronic | Meals · 2025-10-22 | Intellis Adaptivestim | $27 |
| Zimmer Biomet Holdings | Meals · 2025-10-03 | G7 | $10 |
| Medtronic | Meals · 2025-09-11 | Intellis Adaptivestim | $21 |
| Medtronic | Meals · 2025-09-03 | Intellis Adaptivestim | $28 |
| ConvaTec | Meals · 2025-08-04 | Aquacel Ag+ Extra | $41 |
| Medtronic | Meals · 2025-07-28 | Intellis Adaptivestim | $23 |
| Medtronic | Meals · 2025-06-05 | Intellis Adaptivestim | $31 |
| Stryker | Meals · 2025-05-30 | Gamma | $62 |
| Medtronic | Meals · 2025-05-02 | Intellis Adaptivestim | $15 |
| Medtronic | Meals · 2025-03-18 | Intellis Adaptivestim | $28 |
| Uoc USA | Meals · 2025-03-11 | U-Star, Conformity, U2 | $188 |
| Zimmer Biomet Holdings | Meals · 2025-03-10 | Comprehensive Shoulder System | $198 |
| Saxum Surgical | Meals · 2025-02-14 | None | $113 |
| ConvaTec | Meals · 2025-02-10 | Aquacel Ag+ Extra | $19 |
| Medtronic | Meals · 2025-01-17 | Intellis Adaptivestim | $26 |
| Medtronic | Meals · 2025-01-16 | Intellis Adaptivestim | $46 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $284
| Stryker | Gamma | $65 | 2 payments
|
| Globus Medical | Troch Nail | $40 | 1 payment
|
| Biotissue Holdings | None | $39 | 1 payment
|
| Zimmer Biomet Holdings | Persona | $38 | 1 payment
|
| Saxum Surgical | None | $28 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $27 | 1 payment
|
| ConvaTec | Aquacel Ag+ Extra | $19 | 1 payment
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $15 | 1 payment
|
| DePuy Synthes Sales | Monovisc | $13 | 1 payment
|
2023: $49
| Globus Medical | Evo Retrograde | $27 | 1 payment
|
| DePuy Synthes Sales | Orthovisc | $22 | 1 payment
|
2022: $88
| Stryker | Sps | $69 | 1 payment
|
| DePuy Synthes Sales | Na | $19 | 1 payment
|
2021: $89
| Stryker | Na | $47 | 1 payment
|
| Medical Device Business Services | Attune | $42 | 2 payments
|
2020: $60
| Ethicon US | Surgicel Powder | $60 | 2 payments
|
Professional record
- NPI
- 1396066619
- Licence
- CA 141061California A141061: Current · expires 2028-03-31
- Group
- Shahin S Rad MD PC
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207XS0114X (207XS0114X)
- Mailing address
- 16311 Ventura Blvd Ste 1150, Encino, CA, 91436
- NPI first listed
- 2010-06-22
- NPI last updated
- 2019-06-11
This is when the NPI record was last certified, not a medical board exam.